DelNova
Highland, US · Founded 2016 · 1 known investors
DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
BiotechHealthtechMedical Devices
Founders & leadership
DelNova was founded in 2016 by Mary Gardner.
MG

Mary GardnerinChief Executive Officer & Founder
SB
Sameer B. ShahChief Scientist
SY
Steven YoelinChief Medical Strategist
DJ
Dimas JimenezChief Financial Advisor
Board
DB
Daniel BradburyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$810.2K disclosed across 1 round · 2018
▶$810.2KraisedApr 2018 · 3 investors · OtherRule 506(b)
▶$810.2KraisedApr 2018 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel BradburyDirector
- Mary GardnerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $810.2K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapTeknova6 shared keywordsTeknova manufactures custom reagents and solutions for life sciences research and biopharmaceutical manufacturing, including culture media, buffers, cryopreservation systems, and quality control products. The company serves research institutions and biopharmaceutical manufacturers developing therapeutics, with both research-use and GMP-grade manufacturing options.
Grenova5 shared keywordsGrenova develops laboratory technology for washing and reusing pipette tips and microwell plates, aimed at labs seeking to reduce consumable waste and costs. The company operates in the life sciences lab equipment and sustainability space.
Companies competing with DelNova for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does DelNova do?
- DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.
- Who founded DelNova?
- DelNova was founded by Mary Gardner in 2016.
- Who are DelNova's investors?
- DelNova's investors include BioBrit.
- How much funding has DelNova raised?
- DelNova has disclosed $810.2K raised across 1 round.
- Where is DelNova headquartered?
- DelNova is headquartered in Highland, US.